ArticleAlzheimer's research & therapy2025

β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer's and Parkinson's disease.

Bing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.